A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
A Multilevel Intervention to Address Health Disparities in Lung Cancer Screening
1 other identifier
interventional
368
1 country
1
Brief Summary
To test the impact of a multilevel intervention on primary (provider-patient communication, intentions, and knowledge) and secondary (screening referrals and completion) outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable lung-cancer
Started Mar 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 4, 2020
CompletedFirst Posted
Study publicly available on registry
December 19, 2020
CompletedStudy Start
First participant enrolled
March 11, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2026
CompletedDecember 27, 2024
December 1, 2024
1.8 years
December 4, 2020
December 23, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
provider-patient discussion
Discussion about lung screening with the provider ('did you have a discussion with your doctor about lung screening?')
1-week post-visit
lung cancer screening intentions
Screening intentions ('how likely is it that you will undergo lung screening in the next 6-months?')
1-week post-visit
lung cancer screening knowledge
Lung cancer screening knowledge measure
1-week post-visit
Secondary Outcomes (2)
lung cancer screening referrals
6-months
lung cancer screening completion rates
6-months
Study Arms (2)
Multilevel Intervention
EXPERIMENTALNonequivalent Control Group
NO INTERVENTIONInterventions
To target lack of provider-prompted discussion about lung screening, an electronic medical record (EMR) message will be sent to primary care providers prior to scheduled visits with screening-eligible patients to notify them of the patient's eligibility and to encourage discussion of the benefits and limitations of the test. To target patient-level knowledge about lung screening, an outreach specialist will educate screening-eligible patients about the benefits and limitations of the test prior to their visit.
Eligibility Criteria
You may qualify if:
- years old;
- current cigarette smoker or quit within 15 years;
- a 20+ pack-year smoking history;
- non-adherent to lung screening (\>13 months);
- English-speaking;
- scheduled for an upcoming clinic appointment (4 weeks - 8 weeks); and
- able and willing to provide meaningful consent and complete telephone interviews
You may not qualify if:
- Individuals with a history of lung cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
MedStar Health
Washington D.C., District of Columbia, 20007, United States
Related Publications (2)
Williams RM, Whealan J, Sangraula A, Taylor KL, Adams-Campbell L, Miller KE, Glassmeyer K, Yee P, Camidge K, Foley K, Luta G, Lin KW, Barnes R, DuBoyce WF. Providing Reminders and Education Prior to lung cancer screening: Feasibility and acceptability of a multilevel approach to address disparities in lung cancer screening. Transl Behav Med. 2025 Jan 16;15(1):ibaf008. doi: 10.1093/tbm/ibaf008.
PMID: 40231692DERIVEDWilliams RM, Whealan J, Taylor KL, Adams-Campbell L, Miller KE, Foley K, Luta G, Brandt H, Glassmeyer K, Sangraula A, Yee P, Camidge K, Blumenthal J, Modi S, Kratz H. Multilevel approaches to address disparities in lung cancer screening: a study protocol. Implement Sci Commun. 2024 Feb 16;5(1):15. doi: 10.1186/s43058-024-00553-4.
PMID: 38365820DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 4, 2020
First Posted
December 19, 2020
Study Start
March 11, 2024
Primary Completion
December 31, 2025
Study Completion
February 28, 2026
Last Updated
December 27, 2024
Record last verified: 2024-12